• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年糖尿病肾病患者的肠道菌群失调、低度炎症与肾功能损害严重程度

Gut dysbiosis, low-grade inflammation, and renal impairment severity in elderly diabetic nephropathy.

作者信息

Shi Yan-Ping, Pan Zhang-Lei, Zhang Jing, Xue Ling-Yu, Li Ming-Qiang

机构信息

Department of Nephrology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an 271000, Shandong Province, China.

Department of Urology, Tai'an Central Hospital Affiliated to Qingdao University, Tai'an 271000, Shandong Province, China.

出版信息

World J Diabetes. 2025 Aug 15;16(8):108245. doi: 10.4239/wjd.v16.i8.108245.

DOI:10.4239/wjd.v16.i8.108245
PMID:40837334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12362445/
Abstract

BACKGROUND

The specific mechanism of diabetic nephropathy (DN) has not been fully elucidated, and more and more evidence shows that the development of DN is related to intestinal flora imbalance and micro-inflammatory state process, and this mechanism urgently needs to be further clarified by relevant research.

AIM

To investigate the correlation between intestinal microbiota dysbiosis, low-grade inflammatory status, renal function impairment, and disease severity in older patients with DN, in order to provide a basis for the prevention and therapeutic intervention of DN.

METHODS

We enrolled 167 older patients with DN, diagnosed in the Department of Nephrology between June 2020 and June 2023. Eighty-five patients with type 2 diabetes mellitus (without DN) were enrolled to serve as the control group. A one-year follow-up observation was conducted. We compared the differences in gut microbiota composition, levels of inflammatory markers, and renal function indicators between the two groups, and the characteristics of gut microbiota and the changing patterns of inflammatory markers across different stages of disease progression.

RESULTS

In the DN group, the Chao, Ace, and Shannon indices were significantly lower, while the Simpson index was significantly higher than the control group. The relative abundances of and were significantly lower, whereas the relative abundances of , and were significantly higher than those in the control group ( < 0.05). Estimated glomerular filtration rate was positively correlated with the Chao, Ace, and Shannon diversity indices of the gut microbiota, as well as with the relative abundances of , and , and was negatively correlated with the relative abundances of and ( < 0.05). Logistic regression analysis indicated that lower Chao, Ace, and Shannon indices and higher Simpson index were associated with an increased risk of developing DN. After one year of follow-up, patients in the progression group exhibited a significantly greater decrease in Chao, Ace, and Shannon indices and a greater increase in Simpson index than the stable group. The reduction in the relative abundances of and , as well as the increase in and s, were significantly more pronounced in the progression group than in the stable group ( < 0.05). Regression analysis indicated that greater declines in Chao, Ace, and Shannon indices and relative abundance, along with greater increases in Simpson index and relative abundance, were associated with a more rapid decline in renal function.

CONCLUSION

The onset and progression of DN in older patients with diabetes are closely associated with gut microbiota composition. The more severe the dysbiosis, the lower the abundance of beneficial bacteria and the higher the abundance of harmful bacteria, leading to an increased risk of both DN occurrence and disease progression.

摘要

背景

糖尿病肾病(DN)的具体发病机制尚未完全阐明,越来越多的证据表明,DN的发生发展与肠道菌群失调及微炎症状态过程有关,这一机制亟待相关研究进一步阐明。

目的

探讨老年DN患者肠道微生物群失调、低度炎症状态、肾功能损害及疾病严重程度之间的相关性,为DN的预防和治疗干预提供依据。

方法

选取2020年6月至2023年6月在肾内科确诊的167例老年DN患者。选取85例2型糖尿病(无DN)患者作为对照组。进行为期一年的随访观察。比较两组肠道微生物群组成、炎症标志物水平及肾功能指标的差异,以及疾病进展不同阶段肠道微生物群特征和炎症标志物变化模式。

结果

DN组的Chao、Ace和Shannon指数显著低于对照组,而Simpson指数显著高于对照组。[具体菌种名称未给出]的相对丰度显著低于对照组,而[具体菌种名称未给出]的相对丰度显著高于对照组(P<0.05)。估计肾小球滤过率与肠道微生物群的Chao、Ace和Shannon多样性指数以及[具体菌种名称未给出]的相对丰度呈正相关,与[具体菌种名称未给出]的相对丰度呈负相关(P<0.05)。Logistic回归分析表明,较低的Chao、Ace和Shannon指数以及较高的Simpson指数与发生DN的风险增加有关。随访一年后,进展组患者的Chao、Ace和Shannon指数下降幅度显著大于稳定组,Simpson指数升高幅度也更大。进展组中[具体菌种名称未给出]和[具体菌种名称未给出]相对丰度的降低以及[具体菌种名称未给出]和[具体菌种名称未给出]相对丰度的增加显著大于稳定组(P<0.05)。回归分析表明,Chao、Ace和Shannon指数以及[具体菌种名称未给出]相对丰度的更大下降,以及Simpson指数和[具体菌种名称未给出]相对丰度的更大增加与肾功能的更快下降有关。

结论

老年糖尿病患者DN的发生和进展与肠道微生物群组成密切相关。菌群失调越严重,有益菌丰度越低,有害菌丰度越高,导致DN发生和疾病进展的风险增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d8/12362445/bfb5563c4d20/wjd-16-8-108245-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d8/12362445/bfb5563c4d20/wjd-16-8-108245-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29d8/12362445/bfb5563c4d20/wjd-16-8-108245-g001.jpg

相似文献

1
Gut dysbiosis, low-grade inflammation, and renal impairment severity in elderly diabetic nephropathy.老年糖尿病肾病患者的肠道菌群失调、低度炎症与肾功能损害严重程度
World J Diabetes. 2025 Aug 15;16(8):108245. doi: 10.4239/wjd.v16.i8.108245.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
BDE-47 Disrupts Gut Microbiota and Exacerbates Prediabetic Conditions in Mice: Therapeutic Potential of Grape Exosomes and Antioxidants.BDE-47破坏小鼠肠道微生物群并加剧糖尿病前期状况:葡萄外泌体和抗氧化剂的治疗潜力
Toxics. 2025 Jul 29;13(8):640. doi: 10.3390/toxics13080640.
4
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
5
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
6
Gut microbiota dysbiosis characterized by abnormal elevation of in patients with immune-mediated necrotizing myopathy.免疫介导性坏死性肌病患者中,肠道微生物菌群失调的特征为 异常升高。
Front Cell Infect Microbiol. 2023 Aug 25;13:1243512. doi: 10.3389/fcimb.2023.1243512. eCollection 2023.
7
Alterations in vaginal microbiome in women with short cervix: longitudinal study of microbial diversity and impact of vaginal progesterone treatment.宫颈短的女性阴道微生物群的改变:微生物多样性的纵向研究及阴道孕酮治疗的影响
Ultrasound Obstet Gynecol. 2025 Jun 26. doi: 10.1002/uog.29269.
8
Restoring Balance: Probiotic Modulation of Microbiota, Metabolism, and Inflammation in SSRI-Induced Dysbiosis Using the SHIME Model.恢复平衡:使用SHIME模型对SSRI诱导的菌群失调中微生物群、代谢和炎症进行益生菌调节
Pharmaceuticals (Basel). 2025 Jul 29;18(8):1132. doi: 10.3390/ph18081132.
9
The association between gut microbiota composition and cardiometabolic parameters in healthy adults.健康成年人肠道微生物群组成与心脏代谢参数之间的关联。
BMC Microbiol. 2025 Aug 14;25(1):505. doi: 10.1186/s12866-025-04261-4.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Polysaccharides from Cynanchum auriculatum Royle ex Wight ameliorate symptoms of hyperglycemia by regulating gut microbiota in type 2 diabetes mellitus mice.白首乌多糖通过调节2型糖尿病小鼠肠道菌群改善高血糖症状。
Int J Biol Macromol. 2025 Apr;299:139878. doi: 10.1016/j.ijbiomac.2025.139878. Epub 2025 Jan 14.
2
The Gut Microbiome's Influence on Incretins and Impact on Blood Glucose Control.肠道微生物群对肠促胰岛素的影响及其对血糖控制的作用。
Biomedicines. 2024 Nov 27;12(12):2719. doi: 10.3390/biomedicines12122719.
3
Gut microbiota composition and type 2 diabetes: Are these subjects linked Together?
肠道微生物群组成与2型糖尿病:这些受试者有关联吗?
Heliyon. 2024 Oct 16;10(20):e39464. doi: 10.1016/j.heliyon.2024.e39464. eCollection 2024 Oct 30.
4
Rate and risk factors of kidney function decline among South Asians with type 2 diabetes: analysis of the CARRS Trial.2 型糖尿病南亚人群肾功能下降的速率和风险因素:CARRS 试验分析。
BMJ Open Diabetes Res Care. 2024 Aug 16;12(4):e004218. doi: 10.1136/bmjdrc-2024-004218.
5
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.司美格鲁肽对 2 型糖尿病患者慢性肾脏病的影响。
N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24.
6
The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.达格列净对慢性肾脏病的长期影响:时间事件分析。
Nephrol Dial Transplant. 2024 Nov 27;39(12):2040-2047. doi: 10.1093/ndt/gfae106.
7
The causal relationship between gut microbiota and type 2 diabetes: a two-sample Mendelian randomized study.肠道微生物群与 2 型糖尿病之间的因果关系:两样本孟德尔随机研究。
Front Public Health. 2023 Sep 22;11:1255059. doi: 10.3389/fpubh.2023.1255059. eCollection 2023.
8
Bibliometric analysis of intestinal microbiota in diabetic nephropathy.糖尿病肾病肠道微生物的文献计量学分析。
Eur Rev Med Pharmacol Sci. 2023 Sep;27(18):8812-8828. doi: 10.26355/eurrev_202309_33802.
9
Serum metabolomics detected by LDI-TOF-MS can be used to distinguish between diabetic patients with and without diabetic kidney disease.LDI-TOF-MS 检测的血清代谢组学可用于区分伴有和不伴有糖尿病肾病的糖尿病患者。
FEBS Open Bio. 2023 Oct;13(10):1844-1858. doi: 10.1002/2211-5463.13683. Epub 2023 Aug 11.
10
[Visualization analysis of research hotspots in pathogenesis of diabetic nephropathy in China].[中国糖尿病肾病发病机制研究热点的可视化分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2023 Jul 6;57(7):1075-1081. doi: 10.3760/cma.j.cn112150-20230119-00050.